As the elderly population continues to grow exponentially, dry eye disease is becoming increasingly common. In this issue, Sasaki and colleagues identified a NAD+-regulated steroidogenic pathway in the eye that supports the normal function of meibomian glands, and show that increasing the availability of NAD+ can alleviate the dry eye phenotype of aged mice.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lin, J. B. et al. Cell Rep. 17, 69–85 (2016).
Yoshida, M. et al. Cell Metab. 30, 329–342 (2019).
Yoshino, J., Baur, J. A. & Imai, S. I. Cell Metab. 27, 513–528 (2018).
Lin, J. B. & Apte, R. S. Prog. Retin. Eye Res. 67, 118–129 (2018).
Zhang, X. et al. Pharmaceutics 13, 893 (2021).
Cimaglia, G., Votruba, M., Morgan, J. E., André, H. & Williams, P. A. Nutrients 12, 2871 (2020).
Lin, J. B., Tsubota, K. & Apte, R. S. NPJ Aging Mech. Dis. 2, 16003 (2016).
Sasaki, L. et al. Nat. Aging https://doi.org/10.1038/s43587-021-00167-8 (2022).
Golden, M. I. & Meyer, J. J. in StatPearls, https://go.nature.com/3roRI7M (2021).
Sabeti, S., Kheirkhah, A., Yin, J. & Dana, R. Surv. Ophthalmol. 65, 205–217 (2020).
Rubinow, K. B. Mol. Metab. 15, 92–103 (2018).
Mills, K. F. et al. Cell Metab. 24, 795–806 (2016).
Ramsey, K. M. et al. Science 324, 651–654 (2009).
Hägg, S. & Jylhävä, J. eLife 10, e63425 (2021).
Anderson, S. T. & FitzGerald, G. A. Science 369, 1164–1165 (2020).
Acknowledgements
This work was supported by NIH grant R01 EY019287-08 (R.S.A.), P30 EY02687 (Vision Core Grant), Glenn Foundation for Medical Research Award (R.S.A.), Jeffery T Fort Innovation Fund (R.S.A.), the Starr Foundation (R.S.A.) and an unrestricted grant from Research to Prevent Blindness to the John F Hardesty, MD Department of Ophthalmology and Visual Sciences at Washington University School of Medicine in Saint Louis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.S.A. is an inventor on a patent related to NAD+ biology, a cofounder and a member of the clinical and scientific advisory boards of Metro Biotech International. M.Y. is an inventor on a patent related to NAD+/NAMPT biology and receives patent‐licensing fees from Institute for Research on Productive Aging, Japan.
Rights and permissions
About this article
Cite this article
Yoshida, M., Apte, R.S. NAD+ boosting brings tears to aging eyes. Nat Aging 2, 97–99 (2022). https://doi.org/10.1038/s43587-022-00172-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-022-00172-5